vs
Side-by-side financial comparison of Foghorn Therapeutics Inc. (FHTX) and IZEA Worldwide, Inc. (IZEA). Click either name above to swap in a different company.
Foghorn Therapeutics Inc. is the larger business by last-quarter revenue ($9.2M vs $6.1M, roughly 1.5× IZEA Worldwide, Inc.). IZEA Worldwide, Inc. runs the higher net margin — -19.3% vs -234.3%, a 215.0% gap on every dollar of revenue. On growth, Foghorn Therapeutics Inc. posted the faster year-over-year revenue change (223.8% vs -44.9%). Over the past eight quarters, Foghorn Therapeutics Inc.'s revenue compounded faster (35.3% CAGR vs -6.6%).
Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.
IZEA Worldwide, Inc. is a global marketing technology firm that operates platforms linking brands, advertising agencies, and content creators including social media influencers, bloggers, and video creators. It offers end-to-end solutions for influencer marketing campaigns, content creation, performance tracking, and audience engagement, serving clients across consumer goods, retail, technology, and entertainment sectors primarily in North America, Europe, and Asia-Pacific markets.
FHTX vs IZEA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.2M | $6.1M |
| Net Profit | $-21.7M | $-1.2M |
| Gross Margin | — | 45.8% |
| Operating Margin | -258.2% | -26.6% |
| Net Margin | -234.3% | -19.3% |
| Revenue YoY | 223.8% | -44.9% |
| Net Profit YoY | -11.1% | 74.7% |
| EPS (diluted) | $-0.35 | $-0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.2M | $6.1M | ||
| Q3 25 | $8.2M | $8.1M | ||
| Q2 25 | $7.6M | $9.1M | ||
| Q1 25 | $6.0M | $8.0M | ||
| Q4 24 | $2.9M | $11.0M | ||
| Q3 24 | $7.8M | $8.8M | ||
| Q2 24 | $6.9M | $9.1M | ||
| Q1 24 | $5.0M | $7.0M |
| Q4 25 | $-21.7M | $-1.2M | ||
| Q3 25 | $-15.8M | $147.7K | ||
| Q2 25 | $-17.9M | $1.2M | ||
| Q1 25 | $-18.8M | $-142.8K | ||
| Q4 24 | $-19.5M | $-4.6M | ||
| Q3 24 | $-19.1M | $-8.8M | ||
| Q2 24 | $-23.0M | $-2.2M | ||
| Q1 24 | $-25.0M | $-3.3M |
| Q4 25 | — | 45.8% | ||
| Q3 25 | — | 48.6% | ||
| Q2 25 | — | 52.0% | ||
| Q1 25 | — | 44.8% | ||
| Q4 24 | — | 37.8% | ||
| Q3 24 | — | 41.0% | ||
| Q2 24 | — | 43.1% | ||
| Q1 24 | — | 42.9% |
| Q4 25 | -258.2% | -26.6% | ||
| Q3 25 | -226.9% | -4.1% | ||
| Q2 25 | -279.2% | 8.1% | ||
| Q1 25 | -385.0% | -8.2% | ||
| Q4 24 | -840.5% | -28.9% | ||
| Q3 24 | -305.5% | -105.9% | ||
| Q2 24 | -386.6% | -31.8% | ||
| Q1 24 | -558.3% | -58.4% |
| Q4 25 | -234.3% | -19.3% | ||
| Q3 25 | -194.4% | 1.8% | ||
| Q2 25 | -237.3% | 13.2% | ||
| Q1 25 | -316.4% | -1.8% | ||
| Q4 24 | -682.9% | -42.0% | ||
| Q3 24 | -244.9% | -99.3% | ||
| Q2 24 | -333.6% | -24.1% | ||
| Q1 24 | -495.4% | -47.0% |
| Q4 25 | $-0.35 | $-0.07 | ||
| Q3 25 | $-0.25 | $0.01 | ||
| Q2 25 | $-0.28 | $0.07 | ||
| Q1 25 | $-0.30 | $-0.01 | ||
| Q4 24 | $-0.23 | $-0.25 | ||
| Q3 24 | $-0.31 | $-0.52 | ||
| Q2 24 | $-0.45 | $-0.13 | ||
| Q1 24 | $-0.59 | $-0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $80.9M | $50.9M |
| Total DebtLower is stronger | — | $9.1K |
| Stockholders' EquityBook value | $-108.5M | $48.9M |
| Total Assets | $198.1M | $57.5M |
| Debt / EquityLower = less leverage | — | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.9M | $50.9M | ||
| Q3 25 | $89.3M | $51.4M | ||
| Q2 25 | $72.6M | $50.6M | ||
| Q1 25 | $61.0M | $52.2M | ||
| Q4 24 | $55.5M | $51.1M | ||
| Q3 24 | $57.7M | $54.4M | ||
| Q2 24 | $138.9M | $55.6M | ||
| Q1 24 | $79.3M | $56.1M |
| Q4 25 | — | $9.1K | ||
| Q3 25 | — | $18.9K | ||
| Q2 25 | — | $33.7K | ||
| Q1 25 | — | $48.6K | ||
| Q4 24 | — | $63.4K | ||
| Q3 24 | — | $78.3K | ||
| Q2 24 | — | $93.1K | ||
| Q1 24 | — | $108.0K |
| Q4 25 | $-108.5M | $48.9M | ||
| Q3 25 | $-89.7M | $49.9M | ||
| Q2 25 | $-76.7M | $49.4M | ||
| Q1 25 | $-61.7M | $48.3M | ||
| Q4 24 | $-45.5M | $48.8M | ||
| Q3 24 | $-28.3M | $53.3M | ||
| Q2 24 | $-14.3M | $60.8M | ||
| Q1 24 | $-97.5M | $62.5M |
| Q4 25 | $198.1M | $57.5M | ||
| Q3 25 | $205.0M | $57.9M | ||
| Q2 25 | $226.2M | $59.6M | ||
| Q1 25 | $258.7M | $59.3M | ||
| Q4 24 | $284.0M | $62.2M | ||
| Q3 24 | $308.4M | $68.1M | ||
| Q2 24 | $328.6M | $72.7M | ||
| Q1 24 | $255.0M | $76.0M |
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | 0.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-22.3M | $-5.2K |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-22.3M | $-5.2K | ||
| Q3 25 | $-18.9M | $1.2M | ||
| Q2 25 | $-21.0M | $-762.1K | ||
| Q1 25 | $-24.0M | $2.0M | ||
| Q4 24 | $-24.5M | $-2.8M | ||
| Q3 24 | $-21.0M | $-1.4M | ||
| Q2 24 | $-25.5M | $-3.9M | ||
| Q1 24 | $-29.3M | $-3.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-21.0M | $-787.8K | ||
| Q1 25 | $-24.0M | $2.0M | ||
| Q4 24 | $-25.0M | $-2.8M | ||
| Q3 24 | $-21.3M | $-1.4M | ||
| Q2 24 | $-25.6M | $-3.9M | ||
| Q1 24 | $-29.4M | $-3.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -278.2% | -8.6% | ||
| Q1 25 | -403.2% | 25.2% | ||
| Q4 24 | -875.3% | -25.6% | ||
| Q3 24 | -273.0% | -16.2% | ||
| Q2 24 | -371.0% | -43.2% | ||
| Q1 24 | -583.1% | -48.3% |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.3% | 0.3% | ||
| Q1 25 | 0.5% | 0.1% | ||
| Q4 24 | 16.8% | 0.2% | ||
| Q3 24 | 4.0% | 0.3% | ||
| Q2 24 | 0.2% | 0.2% | ||
| Q1 24 | 2.0% | 0.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | 8.05× | ||
| Q2 25 | — | -0.63× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
